In studies reported elsewhere we have demonstrated by the fluorescent antibody technique that serum of patients with disseminated lupus erythematosus contains a globulin factor with a marked affinity for nuclei.7'8 In further investigation of this reaction it was shown that the component of nuclei involved was in the nucleoprotein fraction." During this study a method for titration of this activity of sera was developed which utilized a nucleoprotein extract of calf thymus. With this method it -was possible to obtain reproducible titration of activity of sera in a more refined system than that involving intact nuclei. A preliminary study indicated that an extensive survey of the occurrence of this factor in human sera would be of interest.' These results are the subject of the present report.
In studies reported elsewhere we have demonstrated by the fluorescent antibody technique that serum of patients with disseminated lupus erythematosus contains a globulin factor with a marked affinity for nuclei.7 '8 In further investigation of this reaction it was shown that the component of nuclei involved was in the nucleoprotein fraction." During this study a method for titration of this activity of sera was developed which utilized a nucleoprotein extract of calf thymus. With this method it -was possible to obtain reproducible titration of activity of sera in a more refined system than that involving intact nuclei. A preliminary study indicated that an extensive survey of the occurrence of this factor in human sera would be of interest.' These results are the subject of the present report.
MATERIALS AND METHODS
Fluorescent anttibody techniqiue. Complete details of this technique have been.reported elsewhere and will therefore not be described here."8 The method utilizes a fluorescent dye, chemically bound to antibody, as a visual tracer or stain of a specific antigen. An indirect procedure was employed in application of the technique to this problem. Nucleoprotein was first exposed to the serum being tested, and after excess serum was washed away, to fluorescent rabbit antibody for human gamma globulin. The preparations were then examined under the microscope with a powerful source of ultra-violet light. When fluorescence was observed, it indicated that human gamma globulin from the serum being tested was bound to the insoluble nucleoprotein.
Nutcleoprotein. Calf thymus nucleohistone was prepared by the method of Crampton, Lipschutz, and Chargaff.' After preparation it was dissolved in distilled water adjusted to pH 7.0 by addition of NaHCO3 to approximately .0004 M. This material was divided into aliquots sufficient for several days' work and frozen at -60' C. When prepared and stored in this way the material remained useable for several months, after which noticeable deterioration had occurred. As needed for testing a small quantity was thawed and mixed with an equal volume of 2 M NaCl, forming a clear viscous solution.
Drops of about .05 ml. volume were placed on glass slides and fanned until dry or, during humid weather, placed in enclosed trays over Drierite. Nucleoprotein spots prepared from this concentrated salt solution were found to be the most satisfactory preparations for this work. The homogeneous character of the solution facilitated handling, and the crystalline pattern resulting from drying of the salt gave contrast which aided in evaluation of fluorescent staining. When thoroughly dry, slides were dipped in 0.15 M NaCl to remove excess salt. After draining, excess moisture was blotted from the edges of the slide. Processing with serum and fluorescent antibody was then carried out. HUMAN 
SERA
Sera from 369 individuals were tested for their affinity for nucleohistone spots. Most of the sera were from patients at the Grace-New Haven Community Hospital, New Haven, and the Veterans Adnministration Hospital, West Haven, Connecticut. A few specimens were obtained elsewhere. Sera were frozn at -20°C. from the time received in the laboratory until tested. Results of tests with intact nuclei using some of these sera were the subject of an earlier report. 8 The categories of patients tested are indicated in Table 1 . In collecting the sera an attempt was made to include certain groups which seemed particularly important for purposes of comparison. In addition, large numbers of sera from miscellaneous unrelated diseases have been included.
The patients with disseminated lupus had been diagnosed by the usual criteria. In each case there was agreement on the diagnosis by several competent observers. The L.E. test had been positive sometime during the course of the disease in all except three of these patients. The diagnoses recorded were established without knowledge of results of the tests with fluorescent antibody.
Flutorescent antibody test procedutre. Nucleohistone spots, prepared as described above, were flooded with the serum specimen being tested and placed for 30 minutes in a moist chamber at room temperature. After this they were washed twice for five minutes each with buffered saline. They were then flooded with fluorescent conjugate at a 1: 5 dilution for 30 minutes, washed again as above, drained and mounted in buffered glycerol under a cover slip. Slides were examined under the microscope with the filtered high intensity ultra-violet light source described elsewhere.
The diluent for all serum dilutions and washings in the steps outlined above was isotonic phosphate buffered saline at pH 7.0. Tests were done first with undiluted serum and at 1: 16 dilution, followed by twofold serial dilutions over the range appropriate for determining the end point. To minimize bias during reading, the sequence of the dilutions was mixed in a manner unknown to the person reading the tests. Results were recorded as negative when green fluorescence was not observed, plus-minus (uncertain), and one plus to four plus, depending on the brightness of fluorescent staining. The highest dilution giving at least a one plus reaction was considered the titer of that particular serum. Certain sera gave weak and variable reactions (plus minus-one plus) when tested undiluted, and therefore only sera causing fluorescence at 1: 2 or higher have been tabulated in final analysis of results. Except for the variable weak reactions in some tests with undiluted sera, results of repeated tests at different times on individual serum specimens were quite consistent. In 14 such paired determinations on individual serum specimens the same titer was obtained in 10, and a difference of one dilution in 4. The diagnostic categories of the 369 patients whose serum was studied, and qualitative results of the tests are indicated in Table 1 Treponema immobilization tests had not been done, but it is possible that these represent biologic false positive reactions. The remaining serum which reacted in the test with nucleohistone was a patient with far advanced metastatic bronchogenic carcinoma. There were no features suggestive of lupus in this case.
Consideration of results of titration of the positive sera is essential for full appraisal of results. These are shown in Figure 1 . Reactions by sera of patients not considered to have lupus, indicated by open squares in the illustration, were of relatively low titer. There were two exceptions, both of which were cases of particular interest. One was a young man with findings consistent with rheumatoid arthritis of four years' duration. For several months prior to the date of this test he had had intermittent slight hematuria and albuminuria. On examination he was found to have generalized lymph node enlargement and splenomegaly in addition to evidence of chronic joint disease compatible with rheumatoid arthritis.
Shortly after the date of this test he developed an episode of pleurisy on the right. L.E. tests at this time were negative. Recently he has suffered a second episode of pleurisy, this time on the left side. At the present time both the nucleohistone spot test and the L.E. test are positive. The diagnosis of disseminated lupus erythematosus is clearly established in this case. The second of these individuals was a middle-aged man with scleroderma of several years' duration without evidence of recent activity. He has had moderately severe thrombocytopenia and has also had intermittent abnormal urinary findings. Because of these features the diagnosis of disseminated lupus erythematosus was considered by many to be the proper diagnosis in this case, although the final decision must await further developments in the course of the disease. No other patients not previously considered to have lupus had high titers, and none of those with low titers had clinical features suggestive of disseminated lupus.
It has been indicated previously that many of the patients with lupus were in a remission of variable degree, either sustained spontaneously, or due to the suppressive action of prednisone. Detailed analysis of the clinical course in relation to titer of affinity for nucleohistone will not be described here. On the basis of the results of single tests, and a few individuals from whom repeated serum specimens were obtained, certain general statements can be made. It was evident that patients in remission of some duration tended to have low titers. Patients who were acutely ill, or had recently been so, had titers in the higher range. During the early weeks of therapy with prednisone, however, improvement in the condition of the patient was not necessarily accompanied by an abrupt fall in titer.
DISCUSSION
The data presented here indicate that measurement of this factor could be usefully applied in diagnostic evaluation of patients with the rheumatic diseases and related conditions. In this study the presence of the factor in high titer has invariably been associated with findings consistent with the diagnosis of disseminated lupus. It was not absent from the serum of any established case.* In considering patients with clinical findings suggestive of lupus, the finding of a high titer of this factor appears to be highly * In data reported in connection with our study of the reaction of lupus sera with intact nuclei, a single serum was obtained that failed to react.8 This specimen was from an individual in a long sustained remission under prednisone therapy. The serum had been stored in the refrigerator for 15 months before being received in this laboratory. This specimen was not available when the present tests were being done, but a more recent bleeding was positive at 1: 4 dilution. Although the factor is relatively stable, it is felt that the activity of the first specimen may have been lost during the long storage period. specific and the test useful as a means of establishing or eliminating disseminated lupus erythematosus as a diagnostic possibility. The finding of low titers in occasional patients with diseases closely akin to lupus requires that any conclusions regarding specificity be qualified. These individuals did not have other manifestations of lupus, however, except for a positive L.E. test in some instances. The complete natural history of lupus is often long, and it is well known that in some instances an isolated manifestation such as a chronic biologic false positive serologic test for syphilis," or arthritis resembling rheumatoid arthritis,9 may precede the complete clinical syndrome by long time intervals. The finding of low titer of the factor in serum from some of these patients does not establish the diagnosis of disseminated lupus in such a case. The observation is consistent with prevalent concepts of the disease, however, and further study of the occurrence of the factor in serum of patients not diagnosed as lupus may provide information on the relationship between disseminated lupus and these other conditions. The data suggest the interesting possibility that detection of the factor at low level in rheumatoid arthritis, or in other diseases, may be useful in anticipating future risk of occurrence of disseminated lupus.
It is attractive to reflect on the possibility that the factor may be implicated in the pathogenesis of this disease, especially in view of the recent emphasis on altered nuclear material among the histopathologic findings in lupus.i Evidence available at present does not indicate whether we are dealing with a cause or a result. The concept of lupus as a disease due to "auto-antibodies" has been popular in recent years. The factor under study is part of the gamma globulin fraction of serum proteins, and its properties are compatible with those of a heterogenetic antibody. Robbins, et al., have recently reported complement fixation when sera from some patients with lupus are exposed to intact nuclei or DNA.1" This observation provides additional support for such a concept. However, sera from a considerable proportion of such patients did not possess such complement-fixing activity. The full significance of these observations remains to be determined.
The connection between this factor and that responsible for the L.E. phenomenon is of considerable interest. In an early study Miescher reported that when serum of patients with lupus was incubated with nuclei, the ability to induce L.E. cells was eliminated.1" With application of the fluorescent antibody technique to this problem it was possible to demonstrate more directly that under such conditions globulin is bound to nuclei.8 In another report the procedure applied here was described and it was demonstrated that absorption of lupus serum with nucleoprotein removes L.E. phenomenon activity and this factor simultaneously.! Presumably the factor detected by the method used here is the L.E. factor, and its reaction with nucleoprotein is the first step in the L.E. phenomenon. In data presented elsewhere it was demonstrated that all of these sera reacted with nucleoprotein spots although many failed to induce a positive L.E. test. The data indicated that among sera positive with the nucleoprotein spot test there was no clear relationship between titer of this factor and ability of a particular serum to induce L.E. cells.5 A possible explanation for this finding may be found in recent observations of Finch and Detre,3 who demonstrated that serum of most patients with disseminated lupus has a depressing effect on phagocytosis. Such an effect would tend to obscure any relationship that might exist between titer of a serum factor and induction of L.E. cells.
Experience with the fluorescent antibody technique until quite recently would indicate limited applicability as a generally used diagnostic test. There have recently been improvements in available standard optical systems for fluorescence microscopy. Methods of labelling of antisera with fluorescent dyes have also been simplified.' Furthermore, experience in this laboratory has indicated that fluorescence of spots of nucleoprotein may be determined by gross inspection with an inexpensive source of ultraviolet light. Other methods of detecting the reaction have also been investigated. A technique using iodine131 instead of the fluorescent dye as a label on anti-human globulin has recently been reported. Experience with a modification of the latter procedure indicates that it is an accurate and sensitive means of measuring the factor in human serum.6& SUMMARY Sera from patients with a variety of human diseases have been tested for presence of a globulin factor which reacts with nucleoprotein. The tests were made, and activity of the factor titrated, with an adaptation of the fluorescent antibody technique. The factor was found to be characteristic of sera of patients with disseminated lupus erythematosis, especially when present in high titer. It was also present in low titer in occasional sera of patients with disease syndromes known to be closely related to lupus, especially rheumatoid arthritis and individuals with chronic biologic false positive serologic tests for syphilis. The possible significance of these findings is discussed, and use of this procedure as a diagnostic method considered. 46 Volume 31, September 1958 Lupus globulin factor I FRIOU
